Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of Xiaoer Feire Kechuan oral liquid for pediatric acute bronchitis
CTR20261222Phase 2Active
- Sponsor
- Sunflower Pharmaceutical Group
- Start
- Apr 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xiaoer Feire Kechuan oral liquid in acute bronchitis, sponsored by Sunflower Pharmaceutical Group. Started Apr 2026; status: active.
02
Drugs
Xiaoer Feire Kechuan oral liquid
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on CTR20261222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261222.